| Not Yet Recruiting | Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patie NCT07523152 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Not Yet Recruiting | HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer NCT07425054 | Jennifer Dorth | Phase 2 |
| Not Yet Recruiting | Blood Biomarkers Based Screening for HPV-driven OPC NCT06528353 | UNICANCER | N/A |
| Recruiting | Self-sampling to Optimize Anal Lesion Outcomes NCT07192055 | Medical College of Wisconsin | N/A |
| Recruiting | Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer NCT07296237 | Aarhus University Hospital | — |
| Not Yet Recruiting | Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV NCT07090174 | Weill Medical College of Cornell University | Phase 2 |
| Recruiting | Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis NCT07029152 | Universitair Ziekenhuis Brussel | N/A |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972 | Christian Hinrichs | Phase 1 / Phase 2 |
| Recruiting | HPV Genotype Attribution and Disease Burden of Anal Cancer in China NCT06670495 | Fudan University | — |
| Active Not Recruiting | A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9- NCT06866574 | Xiamen University | Phase 3 |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Recruiting | Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Pre NCT06522256 | ANRS, Emerging Infectious Diseases | N/A |
| Recruiting | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With NCT06263088 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Host Genome Methylation: a Screening Tool in Anal Cancer Detection NCT06792604 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | HPV Infection and Vaginal Microecology in Immunosuppressed Women NCT06619743 | Lan Zhu | — |
| Recruiting | Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer NCT06493019 | Dustin Deming | Phase 2 |
| Recruiting | Multidimensional Examination of Patients with Colorectal and Anal Cancer NCT06562140 | University of Pecs | — |
| Active Not Recruiting | A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese M NCT06465914 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Completed | Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors NCT06331403 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors NCT04889742 | Charite University, Berlin, Germany | Phase 2 |
| Recruiting | Stigma and Psychological profilE in REctal-anal caNcer pAtients NCT06366841 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers NCT06358053 | Corregene Biotechnology Co., Ltd | Phase 1 |
| Recruiting | Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradi NCT06207981 | Federation Francophone de Cancerologie Digestive | Phase 3 |
| Recruiting | A Study Regarding Tissue Response During and After Treatment for Anal Cancer NCT05939401 | Sahlgrenska University Hospital | — |
| Recruiting | HRYZ-T101 Injection for HPV18 Positive Solid Tumor NCT05952947 | HRYZ Biotech Co. | Phase 1 |
| Active Not Recruiting | REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation NCT05902533 | University of Cincinnati | Phase 2 / Phase 3 |
| Recruiting | NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer NCT05572801 | Aarhus University Hospital | N/A |
| Recruiting | SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy NCT05959564 | University of Maryland, College Park | N/A |
| Completed | Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC NCT05510908 | AIDS Malignancy Consortium | — |
| Active Not Recruiting | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors NCT05858736 | OncoC4, Inc. | Phase 1 |
| Terminated | A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and NCT05551117 | MacroGenics | Phase 2 |
| Recruiting | ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES NCT05628194 | University of Minnesota | — |
| Recruiting | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226 | Christian Hinrichs | Phase 2 |
| Unknown | Human Papillomavirus in Young People Epidemiological Research 3 NCT05587725 | Monash University | — |
| Unknown | Human Papillomavirus in Young People Epidemiological Research 4 NCT05587738 | Monash University | — |
| Active Not Recruiting | A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advance NCT05544929 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old NCT05518201 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 1 |
| Not Yet Recruiting | HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL NCT03947775 | University Health Network, Toronto | Phase 2 |
| Unknown | Anal Cancer Risk In Women NCT05835947 | Imperial College London | — |
| Unknown | CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers NCT05122221 | Corregene Biotechnology Co., Ltd | Phase 1 |
| Recruiting | Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens NCT06327568 | European Institute of Oncology | — |
| Unknown | Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma NCT05351931 | Uppsala University Hospital | N/A |
| Unknown | Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients NCT05374252 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
| Completed | Tolerance to Immunomodulatory Nutritional Therapy in Oncology Patients Undergoing Chemotherapy and Radiotherap NCT07021378 | D'Or Institute for Research and Education | N/A |
| Unknown | Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy NCT05233540 | Aarhus University Hospital | — |
| Recruiting | Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer NCT05438836 | Herlev Hospital | — |
| Completed | PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA P NCT05060471 | Sun Yat-sen University | Phase 2 |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Active Not Recruiting | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm NCT04708470 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II NCT05385250 | Karen-Lise Garm Spindler | N/A |
| Recruiting | ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer NCT04792892 | Sahlgrenska University Hospital | — |
| Recruiting | Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG NCT05055635 | University of Aarhus | Phase 2 |
| Active Not Recruiting | Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment NCT05109468 | Institut du Cancer de Montpellier - Val d'Aurelle | — |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Terminated | RTX-321 Monotherapy in Patients With HPV 16+ Tumors NCT04672980 | Rubius Therapeutics | Phase 1 |
| Recruiting | Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. NCT03061435 | Dr. Danielle Vicus | N/A |
| Completed | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination NCT03856437 | University of Maryland, College Park | N/A |
| Active Not Recruiting | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation NCT04141449 | Brigham and Women's Hospital | Phase 2 |
| Completed | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locati NCT04357873 | UNICANCER | Phase 2 |
| Recruiting | Detecting HPV DNA in Anal and Cervical Cancers NCT04857528 | University of Chicago | — |
| Unknown | Anal Injury Screening for High Risk HPV NCT04512508 | Hospital General de México Dr. Eduardo Liceaga | N/A |
| Active Not Recruiting | HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associ NCT04432597 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Phase 1 Study of Oral TP-1454 NCT04328740 | Sumitomo Pharma America, Inc. | Phase 1 |
| Active Not Recruiting | Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies NCT04287868 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Deciphering Mechanisms Underlying Cancer Immunogenicity NCT03958240 | Institut Claudius Regaud | N/A |
| Completed | The Prevent Anal Cancer Palpation Study NCT04090060 | Medical College of Wisconsin | N/A |
| Completed | The Prevent Anal Cancer Self-Swab Study NCT03489707 | Medical College of Wisconsin | N/A |
| Active Not Recruiting | Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Tria NCT04230759 | Goethe University | Phase 2 |
| Completed | Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors NCT04157985 | Dan Zandberg | Phase 3 |
| Recruiting | Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy NCT04094454 | Juergen Debus | N/A |
| Completed | High-Resolution Anoscopy Perceived Discomfort Study NCT04083053 | Wake Forest University Health Sciences | N/A |
| Terminated | Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumor NCT04234113 | SOTIO Biotech AG | Phase 1 |
| Unknown | Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma NCT05835960 | Imperial College London | — |
| Terminated | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03677960 | Antiva Biosciences | Phase 1 |
| Recruiting | Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With A NCT03792854 | Ludwig-Maximilians - University of Munich | — |
| Completed | Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT NCT03506529 | Centre Francois Baclesse | — |
| Completed | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention NCT03346915 | Boston Medical Center | N/A |
| Completed | A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma NCT03519295 | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 |
| Completed | M7824 in Subjects With HPV Associated Malignancies NCT03427411 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepi NCT03302858 | Stephen E. Goldstone | Phase 2 |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03202992 | Antiva Biosciences | Phase 1 |
| Completed | Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula NCT03983174 | Mansoura University | N/A |
| Completed | CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating NCT02981862 | Institut de Cancérologie de Lorraine | N/A |
| Terminated | Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery? NCT02885142 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Pembrolizumab in Metastatic Anal Cancer NCT02919969 | Dana-Farber Cancer Institute | Phase 2 |
| Withdrawn | A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identif NCT02857608 | Cardinal Health 414, LLC | Phase 2 |
| Completed | Programs To Support You During Chemotherapy NCT02489422 | Wake Forest University Health Sciences | N/A |
| Completed | A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal NCT02399813 | Advaxis, Inc. | Phase 2 |
| Completed | Shared Decision Making With Anal Cancer Patients on Radiation Dose NCT02785263 | Vejle Hospital | N/A |
| Active Not Recruiting | PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark NCT05570279 | Aarhus University Hospital | — |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) NCT02628067 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer NCT03381352 | Chinese Academy of Medical Sciences | Phase 2 |
| Terminated | The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men NCT02503111 | University Health Network, Toronto | N/A |
| Completed | Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Conc NCT02949596 | Instituto do Cancer do Estado de São Paulo | — |
| Unknown | Quality of Life in Patients With Anal Cancer NCT02546973 | Sahlgrenska University Hospital | — |
| Completed | Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer NCT02379039 | Umeå University | — |
| Completed | ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy NCT02145416 | University of Oxford | — |
| Unknown | E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM NCT03357991 | Hospital Universitari de Bellvitge | — |
| Unknown | Individual Following in Anal Cancer With PET/CT NCT02697084 | Centre Antoine Lacassagne | — |
| Completed | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers NCT02280811 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions NCT02135419 | AIDS Malignancy Consortium | Phase 3 |
| Completed | Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV NCT01946139 | AIDS Malignancy Consortium | N/A |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Active Not Recruiting | Anal Cancer Radiotherapy Study NCT01937780 | Oslo University Hospital | — |
| Unknown | Functional Outcomes Following Anal Cancer Treatment NCT01853059 | Cambridge University Hospitals NHS Foundation Trust | — |
| Terminated | A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer NCT01671488 | Brown University | Phase 1 / Phase 2 |
| Completed | Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) NCT01651949 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associate NCT01585428 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex NCT01209325 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Assessment of New Radiation Oncology Technologies and Treatments NCT01379872 | Trans Tasman Radiation Oncology Group | — |
| Completed | Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neopl NCT01164722 | AIDS Malignancy Consortium | Phase 3 |
| Terminated | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer NCT01324141 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving R NCT01330186 | Copenhagen University Hospital at Herlev | — |
| Completed | Cancer in Patients With Gabapentin (GPRD) NCT01236053 | GlaxoSmithKline | — |
| Completed | Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test NCT01104181 | Laser Surgery Care | N/A |
| Withdrawn | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers NCT01031056 | Stanford University | — |
| Completed | Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy fo NCT01170299 | Royal Marsden NHS Foundation Trust | N/A |
| Terminated | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim NCT00903396 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Anal Cancer Screening Study NCT00914537 | National Cancer Institute (NCI) | — |
| Completed | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer NCT01526486 | Emory University | N/A |
| Completed | Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in M NCT00955591 | Jonsson Comprehensive Cancer Center | N/A |
| Terminated | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Canc NCT00955240 | UNICANCER | Phase 2 |
| Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gas NCT00836992 | Mayo Clinic | — |
| Completed | B-Receptor Signaling in Cardiomyopathy NCT01135849 | Daniel Bernstein | — |
| Completed | Study of Vaginal Dilator Use After Pelvic Radiotherapy NCT00789893 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Permission to Collect Blood Over Time for Research NCT00767234 | Stanford University | — |
| Unknown | Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-in NCT00666107 | Southern California Institute for Research and Education | N/A |
| Completed | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer NCT00654160 | Mayo Clinic | Phase 1 |
| Completed | Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project NCT00661154 | Stanford University | — |
| Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical NCT00896467 | Centre Oscar Lambret | — |
| Completed | Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near NCT00550589 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients NCT00693173 | The University of Texas Medical Branch, Galveston | — |
| Completed | Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men NCT00501306 | Laser Surgery Care | — |
| Completed | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer NCT00316888 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal C NCT00423293 | Radiation Therapy Oncology Group | Phase 2 |
| Completed | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer NCT00324415 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Image Fusion PET, CT and 3D-ultrasound Examinations NCT00302094 | Rigshospitalet, Denmark | — |
| Terminated | QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT NCT00568425 | Stanford University | — |
| Terminated | Molecular Genetic and Pathological Studies of Anal Tumors NCT00267787 | Stanford University | — |
| Terminated | Chemoradiation-Induced Nausea and Emesis: Quality of Life NCT00394602 | M.D. Anderson Cancer Center | — |
| Completed | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer NCT00093379 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer NCT00532987 | Stanford University | — |
| Completed | Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cance NCT00075868 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia NCT00066430 | AIDS Malignancy Consortium | Phase 1 |
| Terminated | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced NCT00068744 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 / Phase 3 |
| Completed | Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer NCT00059891 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia NCT00052897 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients NCT00502502 | M.D. Anderson Cancer Center | — |
| Completed | Screening for HIV-Associated Anal Cancer NCT00188292 | University Health Network, Toronto | — |
| Completed | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary NCT00025090 | University College London (UCL) Cancer Institute | Phase 3 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer NCT00003652 | UNICANCER | Phase 3 |
| Completed | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer NCT00003596 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer NCT00003427 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Interleukin-12 in Treating Patients With Cancer in the Abdomen NCT00003046 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer NCT00019110 | National Cancer Institute (NCI) | Phase 1 |